From MDS to AML: Genetics of Progression (featuring Prof Lars Bullinger)
Tune in to EHA Unplugged for an engaging chat with Professor Lars Bullinger from Charité University Medicine, Berlin. He'll break down the latest in myeloid disease classification, discussing how new genetic insights are transforming our understanding of MDS and AML.
Discover the hurdles clinicians face, the promise of innovative treatments, and the future of preventive medicine, including the impact of clonal hematopoiesis and cutting-edge sequencing tech.
Host: Prof Kirsten Grønbæk
Guest: Professor Lars Bullinger
Learn More
What did you think of this podcast? Share your opinions with us in…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.